hanixol 50 mg tablets
fontus health limited - mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine
puri-nethol 50mg tablets
aspen pharma trading ltd - mercaptopurine - oral tablet - 50mg
puri-nethol 50mg tablets
ltt pharma limited - mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine
puri-nethol 50 mg tablets
primecrown 2010 limited - 6-mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine
allmercap
link pharmaceuticals ltd - mercaptopurine 20 mg/ml - oral suspension - 20 mg/ml - active: mercaptopurine 20 mg/ml excipient: aspartame potassium sorbate purified water raspberry flavour - concentrated juice (nova) sodium ethyl hydroxybenzoate sodium hydroxide sodium methyl hydroxybenzoate xanthan gum - allmercap is indicated for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients.
mercapt mercaptopurine monohydrate 50 mg tablet bottle
aspen pharmacare australia pty ltd - mercaptopurine monohydrate, quantity: 50 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch - indications as at 5 march 2004: treatment of leukemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. mercapt is also used in the treatment of chronic granulocytic leukaemia.
purinethol tablet
teva canada limited - mercaptopurine - tablet - 50mg - mercaptopurine 50mg - antineoplastic agents
xaluprine 20mgml oral suspension
nova laboratories ltd - mercaptopurine - oral suspension - 20mg/1ml
puri-nethol
glaxosmithkline nz limited - mercaptopurine monohydrate 10mg - tablet - 10 mg - active: mercaptopurine monohydrate 10mg excipient: lactose monohydrate magnesium stearate starch
hanixol 50mg tablets
fontus health ltd - mercaptopurine - oral tablet - 50mg